Voyager Therapeutics, Inc. (VYGR): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

58.69M
Year ended 2025-12-31
+15.2%
3-year compound annual growth
+9.5%
5-year compound annual growth
2018-12-31: 32.07M2019-12-31: 35.90M2020-12-31: 37.35M2021-12-31: 37.67M2022-12-31: 38.36M2023-12-31: 44.57M2024-12-31: 57.67M2025-12-31: 58.69M58.69M
2018-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3158.69M+1.8%2026-03-09, From 2025-01-01
2024-12-3157.67M+29.4%2026-03-09, From 2024-01-01
2023-12-3144.57M+16.2%2026-03-09, From 2023-01-01
2022-12-3138.36M+1.8%2025-03-11, From 2022-01-01
2021-12-3137.67M+0.9%2024-02-28, From 2021-01-01
2020-12-3137.35M+4.0%2023-03-07, From 2020-01-01
2019-12-3135.90M+12.0%2022-03-08, From 2019-01-01
2018-12-3132.07Mn/a2021-02-25, From 2018-01-01